The discovery of medicines for rare diseases.

Abstract excerpt

There is a pressing need for new medicines (new molecular entities; NMEs) for rare diseases as few of the 6800 rare diseases (according to the NIH) have approved treatments. Drug discovery strategies for the 102 orphan NMEs approved by the US FDA between 1999 and 2012 were analyzed to learn from past success: 46 NMEs were first in class; 51 were followers; and five were imaging agents. First-in-class medicines...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Phenotype
• Share to Rare Diseases